Melanin-Concentrating Hormone Receptor 1 Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027
The global melanin-concentrating hormone receptor 1 market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Melanin-concentrating hormone (MCH) is a neuropeptide in the central and peripheral nervous systems that control feeding behaviors and energy metabolism. The major factor contributing to the growth of the market is the increasing prevalence of obesity across the globe. According to the World Health Organization (WHO), an estimated 38.2 million children under the age of 5 years were overweight or obese in 2019. Additionally, the number of overweight children under 5 has increased by nearly 24% since 2000 in Africa. Furthermore, almost half of the children under 5 who were overweight or obese lived in Asia in 2019. Apart from this, in 2020, an estimated 39 million children under the age of 5 were overweight or obese. Moreover, as per the same source, more than 1.9 billion adults, 18 years and older, were overweight out of which over 650 million were obese in 2016.
To Request a Sample of our Report on Melanin-Concentrating
Hormone Receptor 1 Market: https://www.omrglobal.com/request-sample/melanin-concentrating-hormone-receptor-1-market
Some major players in the market
include AstraZeneca Plc, Takeda Pharmaceutical Co., Ltd., and Boehringer
Ingelheim GmbH, among others. The market players are contributing significantly
to the growth of the market by the adoption of various strategies including
mergers & acquisitions, geographical expansion, partnerships and
collaborations, and new product launches, to stay competitive in the market.
For instance, in August 2021, Harmony Biosciences Holdings, Inc. announced the
acquisition of HBS-102 from ConSynance Therapeutics Inc. HBS-102 is a Melanin
Concentrating Hormone Receptor 1 antagonist to offer a novel approach to the
treatment of narcolepsy that includes the symptoms of Rapid Eye Movement (REM)
sleep dysregulation, such as cataplexy, hallucinations and sleeps paralysis.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
AstraZeneca Plc, Takeda Pharmaceutical Co., Ltd., and Boehringer Ingelheim
GmbH, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Melanin-Concentrating Hormone Receptor 1 Market is Available
@ https://www.omrglobal.com/industry-reports/melanin-concentrating-hormone-receptor-1-market
Global Melanin-Concentrating Hormone Receptor 1 Market
Report by Segment
By Type
• ALB-127158(a)
• AZ-13483342
• AZD-3857
• BI-186908
• Others
By Application
• Obesity
• Inflammatory Bowel Disease
• Non-Alcoholic Steatohepatitis
• Others
Global Melanin-Concentrating Hormone Receptor 1 Market
Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment